Abstract:ABSTRACT Hepatitis C virus (HCV) infection is treated with interferon (IFN)-based therapy. The mechanisms by which IFN suppresses HCV replication are not known, and only limited efficacy is achieved with therapy because the virus directs mechanisms to resist the host IFN response. In the present study we characterized the effects of IFN action upon the replication of two distinct quasispecies of an HCV replicon whose encoded NS5A protein exhibited differential abilities to bind and inhibit protein kinase R (PKR). Metabolic labeling experiments revealed that IFN had little overall effect upon HCV protein stability or polyprotein processing but specifically blocked translation of the HCV RNA, such that the replication of both viral quasispecies was suppressed by IFN treatment of the Huh7 host cells. However, within cells expressing an NS5A variant that inhibited PKR, we observed a reduced level of eukaryotic initiation factor 2 alpha subunit (eIF2α) phosphorylation and a concomitant increase in HCV protein synthetic rates, enhancement of viral RNA replication, and a partial rescue of viral internal ribosome entry site (IRES) function from IFN suppression. Assessment of the ribosome distribution of the HCV replicon RNA demonstrated that the NS5A-mediated block in eIF2α phosphorylation resulted in enhanced recruitment of the HCV RNA into polyribosome complexes in vivo but only partially rescued the RNA from polyribosome dissociation induced by IFN treatment. Examination of cellular proteins associated with HCV-translation complexes in IFN-treated cells identified the P56 protein as an eIF3-associated factor that fractionated with the initiator ribosome-HCV RNA complex. Importantly, we found that P56 could independently suppress HCV IRES function both in vitro and in vivo, but a mutant P56 that was unable to bind eIF3 had no suppressive action. We conclude that IFN blocks HCV replication through translational control programs involving PKR and P56 to, respectively, target eIF2- and eIF3-dependent steps in the viral RNA translation initiation process.

Involvement of ERK Pathway in Interferon Alpha-Mediated Antiviral Activity Against Hepatitis C Virus

Interference with Erk and Stat Signaling Pathways and Inhibition of Hepatitis C Virus Replication by Ribavirin

Regulation of Hepatitis C Virus Replication and Gene Expression by the MAPK-ERK Pathway

Activation of the Ras/Raf/MEK Pathway Facilitates Hepatitis C Virus Replication Via Attenuation of the Interferon-JAK-STAT Pathway

IL-1β Enhances the Antiviral Effect of IFN-α on HCV Replication by Negatively Modulating ERK2 Activation.

Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha

Interferon Alpha and Ribavirin Collaboratively Regulate P38 Mitogen-Activated Protein Kinase Signaling in Hepatoma Cells

Regulation of interferon α-triggered Jak-STAT signaling pathway by hepatitis C virus

Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors

A New Clue for the Pathogenesis of Hepatitis C Virus Infection: Activation of the MAPK/ERK Signaling Initiated by Envelope Protein 2

Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro

Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection

Alpha Interferon Induces Distinct Translational Control Programs to Suppress Hepatitis C Virus RNA Replication.

Disparity of Basal and Therapeutically Activated Interferon Signalling in Constraining Hepatitis E Virus Infection

Interaction of L-SIGN with Hepatitis C Virus Envelope Protein E2 Up-Regulates Raf–MEK–ERK Pathway

Antiviral Action Of Interferon-Alpha Against Hepatitis C Virus Replicon And Its Modulation By Interferon-Gamma And Interleukin-8

ERK Signaling is Triggered by Hepatitis C Virus E2 Protein Through DC-SIGN

Interferon Alpha Regulates MAPK and STAT1 Pathways in Human Hepatoma Cells

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line

Suppression of Interferon-Α Signaling by Hepatitis E Virus.